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Background: Diagnosing pulmonary embolism in suspected patients is notoriously
difficult as signs and symptoms are non-specific. Different diagnostic strategies have
been developed, usually combining clinical probability assessment with D-dimer
testing. However, their predictive performance differs across different healthcare
settings, patient subgroups, and clinical presentation, which are currently not
accounted for in the available diagnostic approaches.
Methods: This is a protocol for a large diagnostic individual patient data meta-analysis
(IPDMA) of currently available diagnostic studies in the field of pulmonary embolism.
We searched MEDLINE (search date January 1, 1995, till August 25, 2016) to retrieve
all primary diagnostic studies that had evaluated diagnostic strategies for pulmonary
embolism. Two authors independently screened titles, abstracts, and subsequently full-
text articles for eligibility from 3145 individual studies. A total of 40 studies were
deemed eligible for inclusion into our IPDMA set, and principal investigators from
these studies were invited to participate in a meeting at the 2017 conference from the
International Society on Thrombosis and Haemostasis. All authors agreed on data
sharing and participation into this project. The process of data collection of available
datasets as well as potential identification of additional new datasets based upon
personal contacts and an updated search will be finalized early 2018. The aim is to
evaluate diagnostic strategies across three research domains: (i) the optimal
diagnostic approach for different healthcare settings, (ii) influence of comorbidity on
the predictive performance of each diagnostic strategy, and (iii) optimize and tailor the
efficiency and safety of ruling out PE across a broad spectrum of patients with a new,
patient-tailored clinical decision model that combines clinical items with quantitative
D-dimer testing.
Discussion: This pre-planned individual patient data meta-analysis aims to contribute
in resolving remaining diagnostic challenges of time-efficient diagnosis of pulmonary
embolism by tailoring available diagnostic strategies for different healthcare settings
and comorbidity.
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